BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35952580)

  • 1. Clinical disease course and survival outcomes following disease recurrence in adenoid cystic carcinoma with and without NOTCH signaling pathway activation.
    Feeney L; Hapuarachi B; Adderley H; Rack S; Morgan D; Walker R; Rauch R; Herz E; Kaye J; Harrington K; Metcalf R
    Oral Oncol; 2022 Oct; 133():106028. PubMed ID: 35952580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse Staining for Activated NOTCH1 Correlates With NOTCH1 Mutation Status and Is Associated With Worse Outcome in Adenoid Cystic Carcinoma.
    Sajed DP; Faquin WC; Carey C; Severson EA; H Afrogheh A; A Johnson C; Blacklow SC; Chau NG; Lin DT; Krane JF; Jo VY; Garcia JJ; Sholl LM; Aster JC
    Am J Surg Pathol; 2017 Nov; 41(11):1473-1482. PubMed ID: 28914715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of Notch pathway in patients with adenoid cystic carcinoma of the trachea and its impact on survival.
    Xie M; Wei S; Wu X; Li X; You Y; He C
    Lung Cancer; 2018 Jul; 121():41-47. PubMed ID: 29858025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AL101, a gamma-secretase inhibitor, has potent antitumor activity against adenoid cystic carcinoma with activated NOTCH signaling.
    Ferrarotto R; Mishra V; Herz E; Yaacov A; Solomon O; Rauch R; Mondshine A; Motin M; Leibovich-Rivkin T; Davis M; Kaye J; Weber CR; Shen L; Pearson AT; Rosenberg AJ; Chen X; Singh A; Aster JC; Agrawal N; Izumchenko E
    Cell Death Dis; 2022 Aug; 13(8):678. PubMed ID: 35931701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch-4 contributes to the metastasis of salivary adenoid cystic carcinoma.
    Ding LC; She L; Zheng DL; Huang QL; Wang JF; Zheng FF; Lu YG
    Oncol Rep; 2010 Aug; 24(2):363-8. PubMed ID: 20596622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Profiling and the Impact of Treatment on Outcomes in Adenoid Cystic Carcinoma Type I and II.
    Hanna GJ; Grover P; Elliott A; McGrath J; Xiu J; Sukari A; Johnson JM; Wise-Draper T
    Clin Cancer Res; 2024 May; 30(10):2225-2232. PubMed ID: 38416410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors.
    Ferrarotto R; Mitani Y; Diao L; Guijarro I; Wang J; Zweidler-McKay P; Bell D; William WN; Glisson BS; Wick MJ; Kapoun AM; Patnaik A; Eckhardt G; Munster P; Faoro L; Dupont J; Lee JJ; Futreal A; El-Naggar AK; Heymach JV
    J Clin Oncol; 2017 Jan; 35(3):352-360. PubMed ID: 27870570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of ERBB3 binding protein 1 (EBP1) in salivary adenoid cystic carcinoma and its clinicopathological relevance.
    Sun J; Luo Y; Tian Z; Gu L; Xia SC; Yu Y
    BMC Cancer; 2012 Oct; 12():499. PubMed ID: 23110497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased retinoic acid signaling decreases lung metastasis in salivary adenoid cystic carcinoma by inhibiting the noncanonical Notch1 pathway.
    Zhou MJ; Yang JJ; Ma TY; Feng GX; Wang XL; Wang LY; Ge YZ; Gao R; Liu HL; Shan L; Kong L; Chen XH
    Exp Mol Med; 2023 Mar; 55(3):597-611. PubMed ID: 36879115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma.
    Ho AS; Ochoa A; Jayakumaran G; Zehir A; Valero Mayor C; Tepe J; Makarov V; Dalin MG; He J; Bailey M; Montesion M; Ross JS; Miller VA; Chan L; Ganly I; Dogan S; Katabi N; Tsipouras P; Ha P; Agrawal N; Solit DB; Futreal PA; El Naggar AK; Reis-Filho JS; Weigelt B; Ho AL; Schultz N; Chan TA; Morris LG
    J Clin Invest; 2019 Oct; 129(10):4276-4289. PubMed ID: 31483290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and significance of E-cadherin in adenoid cystic carcinoma of the salivary glands].
    Lai FY; Zhang Q; Wu QL; Qing J; Cao Y
    Ai Zheng; 2007 Sep; 26(9):1025-8. PubMed ID: 17927866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of Notch1 receptor and clinicopathological High-Risk Predictors in lacrimal gland adenoid cystic carcinoma.
    Anjum S; Sen S; Pushker N; Bajaj MS; Kashyap S; Bakhshi S; Chosdol K; Meel R; Sharma MC
    Acta Ophthalmol; 2021 Dec; 99(8):e1467-e1473. PubMed ID: 33675181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between high expression of phosphorylated Akt and mammalian target of rapamycin and improved survival in salivary gland adenoid cystic carcinoma.
    Ouyang DQ; Liang LZ; Ke ZF; Zheng GS; Weng DS; Yang WF; Su YX; Liao GQ
    Head Neck; 2017 Jun; 39(6):1145-1154. PubMed ID: 28230926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and significance of notch signaling pathway in salivary adenoid cystic carcinoma.
    Bell D; Hanna EY; Miele L; Roberts D; Weber RS; El-Naggar AK
    Ann Diagn Pathol; 2014 Feb; 18(1):10-3. PubMed ID: 24238845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher positive lymph node ratio indicates poorer distant metastasis-free survival in adenoid cystic carcinoma patients with nodal involvement.
    Liu Z; Fang Z; Dai T; Zhang C; Sun J; He Y
    J Craniomaxillofac Surg; 2015 Jul; 43(6):751-7. PubMed ID: 25958766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-NOTCH1 therapy with OMP-52 M51 inhibits salivary adenoid cystic carcinoma by depressing epithelial-mesenchymal transition (EMT) process and inducing ferroptosis.
    Li R; Hu Z; Qiao Q; Zhou D; Sun M
    Toxicol Appl Pharmacol; 2024 Mar; 484():116825. PubMed ID: 38253083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic Adenoid Cystic Carcinoma: Genomic Landscape and Emerging Treatments.
    de Sousa LG; Jovanovic K; Ferrarotto R
    Curr Treat Options Oncol; 2022 Aug; 23(8):1135-1150. PubMed ID: 35854180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NOTCH1 signaling contributes to cell growth, anti-apoptosis and metastasis in salivary adenoid cystic carcinoma.
    Su BH; Qu J; Song M; Huang XY; Hu XM; Xie J; Zhao Y; Ding LC; She L; Chen J; Lin LS; Lin X; Zheng DL; Lu YG
    Oncotarget; 2014 Aug; 5(16):6885-95. PubMed ID: 25149541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Notch-1 knockdown suppresses proliferation, migration and metastasis of salivary adenoid cystic carcinoma cells.
    Chen W; Cao G; Yuan X; Zhang X; Zhang Q; Zhu Y; Dong Z; Zhang S
    J Transl Med; 2015 May; 13():167. PubMed ID: 25990317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of podoplanin in salivary gland adenoid cystic carcinoma and its association with distant metastasis and clinical outcomes.
    Wu HM; Ren GX; Wang LZ; Zhang CY; Chen WT; Guo W
    Mol Med Rep; 2012 Aug; 6(2):271-4. PubMed ID: 22580922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.